JP2016520594A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016520594A5 JP2016520594A5 JP2016515131A JP2016515131A JP2016520594A5 JP 2016520594 A5 JP2016520594 A5 JP 2016520594A5 JP 2016515131 A JP2016515131 A JP 2016515131A JP 2016515131 A JP2016515131 A JP 2016515131A JP 2016520594 A5 JP2016520594 A5 JP 2016520594A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- fragment
- composition
- combination
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012634 fragment Substances 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 12
- 208000027866 inflammatory disease Diseases 0.000 claims 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 8
- 206010039710 Scleroderma Diseases 0.000 claims 5
- 239000000427 antigen Substances 0.000 claims 5
- 102000036639 antigens Human genes 0.000 claims 5
- 108091007433 antigens Proteins 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 4
- 208000035475 disorder Diseases 0.000 claims 4
- 230000003176 fibrotic effect Effects 0.000 claims 4
- 102100021943 C-C motif chemokine 2 Human genes 0.000 claims 2
- 101000897480 Homo sapiens C-C motif chemokine 2 Proteins 0.000 claims 2
- 101001043352 Homo sapiens Lysyl oxidase homolog 2 Proteins 0.000 claims 2
- 102100021948 Lysyl oxidase homolog 2 Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000005777 Lupus Nephritis Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 206010025135 lupus erythematosus Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 201000008383 nephritis Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361826692P | 2013-05-23 | 2013-05-23 | |
| US61/826,692 | 2013-05-23 | ||
| PCT/US2014/039437 WO2014190316A1 (en) | 2013-05-23 | 2014-05-23 | Anti-ccl2 and anti-loxl2 combination therapy for treatment of scleroderma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016520594A JP2016520594A (ja) | 2016-07-14 |
| JP2016520594A5 true JP2016520594A5 (enExample) | 2017-06-29 |
| JP6587609B2 JP6587609B2 (ja) | 2019-10-09 |
Family
ID=50983195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016515131A Active JP6587609B2 (ja) | 2013-05-23 | 2014-05-23 | 強皮症治療のための抗ｃｃｌ２及び抗ｌｏｘｌ２併用療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11059906B2 (enExample) |
| EP (1) | EP2999484B1 (enExample) |
| JP (1) | JP6587609B2 (enExample) |
| CN (1) | CN105358175B (enExample) |
| AU (2) | AU2014268316B2 (enExample) |
| BR (1) | BR112015029300A2 (enExample) |
| CA (1) | CA2912443A1 (enExample) |
| EA (1) | EA201591993A1 (enExample) |
| HK (1) | HK1224174A1 (enExample) |
| MX (1) | MX371412B (enExample) |
| WO (1) | WO2014190316A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3458157A4 (en) * | 2016-05-19 | 2020-05-27 | Momenta Pharmaceuticals, Inc. | METHOD FOR TREATING DISEASES RELATING TO FIBROSE AND SYSTEMIC Sclerosis |
| US10610104B2 (en) | 2016-12-07 | 2020-04-07 | Progenity, Inc. | Gastrointestinal tract detection methods, devices and systems |
| WO2018112264A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
| CN107794267B (zh) * | 2017-03-14 | 2021-03-26 | 湖南大学 | 一种靶向pd1-pdl1的双特异性核酸适体及其衍生物 |
| WO2020106757A1 (en) | 2018-11-19 | 2020-05-28 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
| CN110767262B (zh) * | 2019-09-18 | 2021-02-26 | 复旦大学 | 一种基于结构的核酸适配体优化设计方法 |
| CN115666704B (zh) | 2019-12-13 | 2025-09-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
| WO2021122733A1 (en) * | 2019-12-18 | 2021-06-24 | F. Hoffmann-La Roche Ag | Bispecific anti-ccl2 antibodies |
| WO2023097111A2 (en) * | 2021-11-29 | 2023-06-01 | Riptide Bioscience, Inc. | Methods and compositions for treating calcinosis associated conditions |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5132405A (en) | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| JPS6412935A (en) | 1987-07-02 | 1989-01-17 | Mitsubishi Electric Corp | Constant-speed travel device for vehicle |
| US6010902A (en) | 1988-04-04 | 2000-01-04 | Bristol-Meyers Squibb Company | Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity |
| US5601819A (en) | 1988-08-11 | 1997-02-11 | The General Hospital Corporation | Bispecific antibodies for selective immune regulation and for selective immune cell binding |
| DE3909708A1 (de) | 1989-03-23 | 1990-09-27 | Boehringer Mannheim Gmbh | Verfahren zur herstellung bispezifischer antikoerper |
| SG46445A1 (en) | 1990-01-26 | 1998-02-20 | Immunomedics Inc | Vaccines against cancer and infectious diseases |
| DE4118120A1 (de) | 1991-06-03 | 1992-12-10 | Behringwerke Ag | Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung |
| US6004555A (en) | 1992-03-05 | 1999-12-21 | Board Of Regents, The University Of Texas System | Methods for the specific coagulation of vasculature |
| WO1994008038A1 (en) | 1992-10-02 | 1994-04-14 | Trustees Of Dartmouth College | Bispecific reagents for redirected targeting of low density lipoprotein |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US20020025317A1 (en) | 2000-07-20 | 2002-02-28 | Schering Ag | Bispecific monoclonal antibodies to IL-12 and IL-18 |
| CA2468733C (en) * | 2001-11-30 | 2013-06-11 | Biogen Idec Ma Inc. | Antibodies against monocyte chemotactic proteins |
| EP2185198B1 (en) * | 2007-08-02 | 2015-01-14 | Gilead Biologics, Inc. | Lox and l0xl2 inhibitors and uses thereof |
| BR112012004387A2 (pt) | 2009-08-28 | 2015-09-08 | Vlst Corp | anticorpos anticinas que se l igam a múltiplas quimiocinas cc. |
| RU2015108348A (ru) * | 2010-02-04 | 2015-07-20 | Джилид Байолоджикс, Инк. | Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения |
| BR112014029013A2 (pt) * | 2012-05-22 | 2017-09-19 | Shire Human Genetic Therapies | anticorpos de anti-ccl2 para tratamento de esclerodermia |
-
2014
- 2014-05-23 EA EA201591993A patent/EA201591993A1/ru unknown
- 2014-05-23 HK HK16109679.1A patent/HK1224174A1/zh unknown
- 2014-05-23 BR BR112015029300A patent/BR112015029300A2/pt not_active Application Discontinuation
- 2014-05-23 CA CA2912443A patent/CA2912443A1/en not_active Abandoned
- 2014-05-23 US US14/893,486 patent/US11059906B2/en active Active
- 2014-05-23 AU AU2014268316A patent/AU2014268316B2/en active Active
- 2014-05-23 MX MX2015016054A patent/MX371412B/es active IP Right Grant
- 2014-05-23 EP EP14732752.2A patent/EP2999484B1/en active Active
- 2014-05-23 JP JP2016515131A patent/JP6587609B2/ja active Active
- 2014-05-23 CN CN201480036627.0A patent/CN105358175B/zh active Active
- 2014-05-23 WO PCT/US2014/039437 patent/WO2014190316A1/en not_active Ceased
-
2019
- 2019-09-24 AU AU2019236656A patent/AU2019236656A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016520594A5 (enExample) | ||
| JP2017518258A5 (enExample) | ||
| JP2014205674A5 (enExample) | ||
| JP2017113019A5 (enExample) | ||
| JP2021502984A5 (enExample) | ||
| JP2016502515A5 (enExample) | ||
| JP2018504907A5 (enExample) | ||
| JP2017531427A5 (enExample) | ||
| JP2017113028A5 (enExample) | ||
| JP2016183160A5 (enExample) | ||
| JP2018510151A5 (enExample) | ||
| JP2016183153A5 (enExample) | ||
| JP2017501130A5 (enExample) | ||
| EA202090401A1 (ru) | Анти-tim-3 антитела и их применение | |
| JP2013539454A5 (enExample) | ||
| PE20161311A1 (es) | Anticuerpos especificos del receptor del factor 1 de crecimiento similar a la insulina y usos de los mismos. | |
| MX2025002470A (es) | Combinaciones de anticuerpos anti-c5 y usos de las mismas | |
| JP2017501848A5 (enExample) | ||
| MY163133A (en) | Humanized il-25 antibodies | |
| NZ758300A (en) | Human anti-semaphorin 4d antibody | |
| JP2012530487A5 (enExample) | ||
| JP2017014254A5 (enExample) | ||
| MX2017004970A (es) | Anticuerpos que se unen a ccr6 y sus usos. | |
| JP2021500874A5 (enExample) | ||
| WO2015187521A3 (en) | Anti-blys antibodies |